Premier Path Wealth Partners LLC Acquires New Stake in The Clorox Company $CLX

Premier Path Wealth Partners LLC bought a new stake in The Clorox Company (NYSE:CLX) during the first quarter, HoldingsChannel.com reports. The institutional investor bought 5,302 shares of the company’s stock, valued at approximately $549,000.

Several other institutional investors and hedge funds have also bought and sold shares of CLX. State Street Corp increased its position in shares of Clorox by 3.5% during the 3rd quarter. State Street Corp now owns 8,434,277 shares of the company’s stock valued at $1,039,946,000 after purchasing an additional 282,794 shares during the last quarter. Invesco Ltd. boosted its holdings in shares of Clorox by 22.1% in the fourth quarter. Invesco Ltd. now owns 4,880,341 shares of the company’s stock worth $492,085,000 after buying an additional 884,751 shares during the last quarter. Geode Capital Management LLC grew its position in Clorox by 0.3% during the fourth quarter. Geode Capital Management LLC now owns 3,172,233 shares of the company’s stock valued at $318,613,000 after buying an additional 10,060 shares during the period. Van ECK Associates Corp grew its position in Clorox by 15.7% during the fourth quarter. Van ECK Associates Corp now owns 3,136,405 shares of the company’s stock valued at $316,244,000 after buying an additional 426,433 shares during the period. Finally, Two Sigma Investments LP increased its holdings in Clorox by 33.8% during the third quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock valued at $214,564,000 after buying an additional 439,797 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other Clorox news, Director Pierre R. Breber bought 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 5th. The stock was purchased at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the transaction, the director owned 18,000 shares of the company’s stock, valued at $1,544,760. This trade represents a 38.46% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 0.63% of the company’s stock.

Clorox Trading Up 0.8%

Shares of Clorox stock opened at $97.15 on Friday. The company has a market capitalization of $11.75 billion, a P/E ratio of 15.77, a P/E/G ratio of 0.45 and a beta of 0.54. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The company has a fifty day moving average of $94.21 and a 200 day moving average of $104.28. The Clorox Company has a fifty-two week low of $84.70 and a fifty-two week high of $132.03.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. The business had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.Clorox’s revenue for the quarter was up .1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.45 EPS. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, sell-side analysts anticipate that The Clorox Company will post 5.61 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

CLX has been the topic of several analyst reports. JPMorgan Chase & Co. dropped their price target on shares of Clorox from $99.00 to $95.00 and set an “underweight” rating on the stock in a research note on Friday, May 1st. Barclays decreased their target price on Clorox from $102.00 to $85.00 and set an “underweight” rating on the stock in a report on Friday, May 1st. Jefferies Financial Group lowered their target price on Clorox from $139.00 to $125.00 and set a “buy” rating on the stock in a research report on Monday, May 4th. Evercore restated an “underperform” rating and issued a $110.00 price target on shares of Clorox in a research report on Friday, May 1st. Finally, Royal Bank Of Canada decreased their price objective on Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a research note on Thursday, April 9th. One equities research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have issued a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Reduce” and an average target price of $103.40.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.